Luca Zammataro Selected Research

Luca Zammataro Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 02/2010
8	Carcinoma (Carcinomatosis) 11/2021 - 10/2016
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2017
4	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2010
3	Carcinosarcoma 02/2020 - 10/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 10/2019
3	Inflammation (Inflammations) 01/2018 - 02/2010
3	Ovarian Epithelial Carcinoma 10/2017 - 01/2017
2	Triple Negative Breast Neoplasms 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
2	Adenocarcinoma 01/2020 - 11/2019
2	Pneumonia (Pneumonitis) 08/2018 - 01/2018
1	Turcot syndrome 01/2022
1	Microsatellite Instability 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019
1	Hemorrhage 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Uterine Neoplasms (Uterine Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

8	Immunoconjugates (Immunoconjugate)IBA 11/2021 - 01/2017
5	sacituzumab govitecanIBA 02/2020 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2010
3	Surface Antigens (Surface Antigen)IBA 01/2020 - 01/2020
3	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2022 - 01/2018
2	pertuzumabIBA 11/2021 - 10/2017
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 10/2017
2	Aurora Kinase AIBA 01/2021 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2020
2	ParaffinIBA 01/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2019
2	neratinibIBA 11/2019 - 05/2017
2	AfatinibIBA 11/2019 - 01/2019
2	Chemokine ReceptorsIBA 01/2018 - 02/2010
2	ChemokinesIBA 01/2018 - 02/2010
2	trastuzumab duocarmazineIBA 10/2017 - 01/2017
2	DuocarmycinsIBA 10/2017 - 01/2017
2	Ado-Trastuzumab EmtansineIBA 10/2017 - 01/2017
1	NucleotidesIBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 11/2021
1	DHES0815AIBA 11/2021
1	Alkylating AgentsIBA 11/2021
1	EpitopesIBA 11/2021
1	EnzymesIBA 01/2021
1	GlutaminaseIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	linifanibIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Cytidine DeaminaseIBA 11/2019
1	copanlisibIBA 11/2019
1	olaparibIBA 10/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2019
1	Adenosine Diphosphate (ADP)IBA 10/2019
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 10/2019
1	CarcinogensIBA 08/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	binimetinibIBA 08/2018
1	SteroidsIBA 08/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	MitogensIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Notch ReceptorsIBA 01/2018
1	ClaudinsIBA 01/2018
1	Folate Receptor 1IBA 01/2018
1	mirvetuximab soravtansineIBA 01/2018
1	Monoclonal AntibodiesIBA 10/2017
1	PlatinumIBA 01/2017
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2017
1	cyclopentenyl cytosineIBA 01/2017
1	Diphtheria ToxinIBA 01/2017
1	Clostridium enterotoxinIBA 01/2017
1	Claudin-3IBA 01/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Nucleosomes (Nucleosome)IBA 10/2016
1	Histones (Histone)IBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	LigandsIBA 11/2010
1	Conditioned Culture MediaIBA 07/2010
1	factor AIBA 07/2010

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2021 - 01/2017
5	Therapeutics 01/2021 - 02/2010
3	Intravenous Administration 02/2020 - 01/2020
1	Salvage Therapy 01/2018
1	Intraperitoneal Injections 01/2017